OncoTriage. Поиск наилучшего лечения для вашего пациента

ХМПН

Efficacy and Safety of Ropeginterferon Alfa-2b in Low-Risk Polycythemia Vera.

These findings suggest that Ropeg is a promising treatment option for low-risk PV by effectively reducing the need for phlebotomy and demonstrating efficacy and safety.

DOI: 10.4143/crt.2025.552

Lee JY, Yoon SS, Yang DH, Sohn SK, Yoon SY, Bang SM, Lee GW, Choi CW, Choi EJ, Cheong JW, Park YH, Lee SE

Cancer research and treatment, 2025-06-28

НОВАЯ СТАТЬЯ

Treatment patterns and blood count control in 10,112 patients with polycythemia vera.

This real-world evidence highlights the importance of considering alternative therapies for patients whose initial treatment regimen does not provide adequate clinical benefit.

DOI: 10.1080/17474086.2025.2520316

Pemmaraju N, Yu J, Vasudevan A, Qureshi H, Braunstein E, Chojecki A

Expert review of hematology, 2025-06-28

Ponatinib may make allogeneic hematopoietic stem cell transplantation unnecessary for CML-BC under specific conditions, such as cases: a case series of CML-BC treated with ponatinib and no transplantation.

У данной статьи нет абстракта.

DOI: 10.1080/10428194.2025.2521646

Koyabu S, Onaka T, Imada K

Leukemia & lymphoma, 2025-06-28

Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" Questions.

Chronic myeloid leukemia (CML) has undergone a transformation from a fatal disease to a chronic, manageable condition with the advent of tyrosine kinase inhibitors (TKIs), particularly imatinib...

DOI: 10.1111/ejh.70000

Bruzzese A, Vigna E, Martino EA, Amodio N, Labanca C, Mendicino F, Lucia E, Olivito V, Morabito F, Gentile M

European journal of haematology, 2025-06-25

Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis.

With the incorporation of effective therapies for myelofibrosis (MF), accurately predicting outcomes after allogeneic hematopoietic cell transplantation (allo-HCT) is crucial for determining the optimal timing for this procedure...

DOI: 10.1182/blood.2024027287

Hernández-Boluda JC, Mosquera-Orgueira A, Gras L, Koster L, Tuffnell J, Kröger N, Gambella M, Schroeder T, Robin M, Sockel K, Passweg J, Blau IW, Yakoub-Agha I, Van Dijck R, Stelljes M, Sengeloev H, Vydra J, Platzbecker U, de Witte M, Baron F, Carlso

Blood, 2025-06-28

Наверх

ХМПН

Efficacy and Safety of Ropeginterferon Alfa-2b in Low-Risk Polycythemia Vera.

Treatment patterns and blood count control in 10,112 patients with polycythemia vera.

Ponatinib may make allogeneic hematopoietic stem cell transplantation unnecessary for CML-BC under specific conditions, such as cases: a case series of CML-BC treated with ponatinib and no transplantation.

Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" Questions.

Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis.

Свяжитесь с нами

Вход в аккаунт

Восстановление пароля